My APOE4/4 Senolytic Protocol: Intermittent pulsing of Fisetin/Quercetin/Dasatinib to kill off "zombie" cells.

Why Senescent Cells Belong in the APOE4 Conversation

Alzheimer’s disease is usually discussed in terms of amyloid and tau. But those pathologies do not arise in isolation. Aging biology sets the stage — and one of the most consequential, yet under-appreciated, contributors to age-related disease is cellular senescence.

Senescent cells are cells that have exited the cell cycle but refuse to die. They are often referred to as “zombie cells”. Instead, they secrete a potent mix of inflammatory cytokines, proteases, and growth factors — the senescence-associated secretory phenotype (SASP) — which damages surrounding tissue and amplifies inflammation.

For APOE4 carriers, this matters disproportionately.

In the brain, senescent cells have been identified in astrocytes, microglia, endothelial cells, and oligodendrocyte lineage cells — precisely the cell types already vulnerable in APOE4 brains. These cells govern neuroinflammation, vascular integrity, metabolic support, and synaptic health, all of which tend to show earlier dysfunction in APOE4 carriers

Why APOE4 Requires a Different Strategy

APOE4 biology is characterized by:

• Higher baseline inflammation

• Chronically primed microglia

• Earlier blood–brain barrier vulnerability

• Greater sensitivity to immune, thyroid, and mitochondrial suppression

This means that strategies tolerated by the general population could backfire when applied continuously in APOE4 carriers.

Senolytics are a perfect example.

They are powerful tools — but they are not meant to be taken every day.

For APOE4 carriers, indiscriminate or continuous senolytic pressure risks disrupting immune surveillance, thyroid signaling, and mitochondrial resilience — systems that are already more fragile.

The Study That Changed the Alzheimer’s Conversation

One of the most influential studies in this field demonstrated that clearing senescent astrocytes and microglia in a tau mouse model reduced tau pathology and preserved cognitive function.

This does not prove human prevention. But it strongly suggests that senescent glial cells are active contributors to neurodegeneration rather than innocent bystanders — a finding with particular relevance for APOE4 brains that enter inflammatory and vascular stress states earlier.

My Experience With Potent Senolytics (and Why It Shaped My Approach)

Under the guidance of the late Dr. Alan Green, Dasatinib was discussed and prescribed for me as part of a senolytic strategy to follow. Despite extensive research prior to taking the first dose, and taking only half of the prescribed dose, I experienced significant side effects…. including a clear episode of tachycardia — unmistakable physiologic disruption along with significant nausea and strong headache.

It reinforced several truths:

• Dasatinib is a potent oncology drug, not a nutraceutical

• Individual sensitivity varies widely

• Even “low” doses can have systemic effects

• Strong Senolytics are not something to experiment with casually

To reduce side effects, I later broke the dose into smaller fractions (+/- 25 mg) staggered over the day in minimum 6 hour increments, maintaining exposure while avoiding excessive peak levels. Even so, the experience solidified my conviction: respect the biology, respect the drug, and err on the side of caution.

Why I Do Not Take Senolytics Daily

Senescent cells accumulate slowly. They do not require daily pressure.

Daily senolytics can:

• Blunt hormetic signaling

• Interfere with thyroid hormone transport

• Suppress immune surveillance

• Disrupt mitochondrial signaling

Instead, I follow the logic used in most animal models and early human studies:

Short pulses, followed by long recovery periods.

The Senolytics I Use

My core senolytics are:

• Quercetin

• Fisetin

  
  They target overlapping but not identical senescent cell populations, providing broader coverage without aggressive dosing.

• An additional 100 mg Dasatinib total, micro-dosed over 24-36 hours during pulse periods only, to extend coverage without increasing peak exposure

This micro-dose is never taken daily and never outside pulse windows.

My Annual APOE4/4 Senolytic Calendar

Monthly Maintenance Pulses (8× per year)

January · February · April · May · July · August · October · November

• Duration: 2 consecutive days

• Each day:

  • Quercetin: 1,000 mg

  • Fisetin: 1,000–1,500 mg

• Added micro-dose (first day only):

  • 100 mg Dasatinib total, split into 25 mg × 4 doses

  • Morning · Midday · Late afternoon · Early evening

  • I skip the Dasatinib bedtime dosing if I am experiencing any unpleasant side effects and take the next morning.

Purpose:
Maintenance clearance — preventing senescent immune and glial cells from re-establishing a chronically inflamed baseline. It’s worth noting that Quercetin and Fisetin are both fat soluble so need to be taken with fat.

Quarterly Deep Reset Pulses (3× per year)

March · June · September

• Duration: 4 consecutive days

• Each day:

  • Quercetin: 1,000 mg

  • Fisetin: 1,500–2,000 mg

• Same micro-dose:

  • 100 mg Dasatinib total over 24 hours, split into 4-5 increment doses

I do not increase beyond this.

Purpose:
Broader systemic and CNS-adjacent senescent clearance, particularly relevant for aging microglia and endothelium.

Mandatory Senolytic Rest Month

December

• No quercetin

• No fisetin

• No Dasatinib micro-dose

• No other senolytics or aggressive polyphenols

This rest period matters. It allows immune surveillance, hormetic signaling, thyroid transport, and mitochondrial pathways to fully reset.

Guardrails I Consider Non-Negotiable

• I never overlap senolytic pulses with rapamycin (minimum 4 days apart)

• I space senolytics several hours away from thyroid medication

• I avoid stacking additional polyphenols on pulse days

• I do not fast aggressively or perform intense HIIT during pulses

How I Know It’s Working

I don’t expect fireworks during pulse days. Benefits show up weeks later, not immediately.

What I watch:

• hs-CRP trends

• Sleep depth and HRV

• Cognitive clarity

• Subtle inflammation markers

Quiet, cumulative improvement beats dramatic short-term effects.

Final Thoughts

This is my personal protocol, shaped by:

• APOE4/4 biology

• Inflammation sensitivity

• Thyroid considerations

• Mitochondrial health

• Long-term sustainability

I believe senolytics should feel like spring cleaning, not daily housekeeping.

Disclaimer

This post is for educational purposes only and does not constitute medical advice. It’s what I do, and what I know works for my body! Dasatinib is a prescription medication with significant risks and should only be used under medical supervision.